KIORA PHARMACEUTICALS, INC. - Common Stock, $0.01 par value (KPRX)

CUSIP: 49721T507

Q3 2025 13F Holders as of 30 Sep 2025

Holder snapshot 6 signals
Share change
-315,674
SEC-reported price per share
$2.78
Number of holders
17
Value change
-$910,084
Number of buys
9
Number of sells
7
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
4,439,655

Security key

49721T507

Report period

Q3 2025

Institutions

17

Top holders

10

Ownership snapshot

Top reported holders of KPRX - KIORA PHARMACEUTICALS, INC. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
0/15
Latest evidence
30 Jun 2025
3/4/5 13F 13D/G Highest disclosed value: $3,006,550 15 rows are not safely comparable across share classes. 13D/G row: GOLDMAN SACHS GROUP INC Showing 1-6 of 15 holder rows.

Quick read

ARMISTICE CAPITAL, LLC has the largest disclosed position value at $3.01M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens GOLDMAN SACHS GROUP INC's linked filing trail.
Disclosed position value Top 5
ARMISTICE CAPITAL, LLC $3.01M
AIGH Capital Management LLC $623.1K
Nantahala Capital Management, LLC $608K
Stonepine Capital Management, LLC $512.6K
ADAR1 Capital Management, LLC $481.3K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ARMISTICE CAPITAL, LLC
3/4/5
10%+ Owner
—
denominator unverified
$3,006,550
785,000 shares
— 30 Jul 2021
AIGH Capital Management LLC
13F
Company
13F
—
denominator unverified
$623,074
216,345 shares
— 30 Jun 2025
Nantahala Capital Management, LLC
13F
Company
13F
—
denominator unverified
$607,997
211,110 shares
— 30 Jun 2025
Stonepine Capital Management, LLC
13F
Company
13F
—
denominator unverified
$512,640
178,000 shares
— 30 Jun 2025
ADAR1 Capital Management, LLC
13F
Company
13F
—
denominator unverified
$481,280
167,111 shares
— 30 Jun 2025
Velan Capital Investment Management LP
13F
Company
13F
—
denominator unverified
$352,002
122,223 shares
— 30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
17
Shares
616,169
Rows available
17
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2026 Across Filers

Q2 2026 holders
22
Q3 2025 holders
17
Holder diff
-5
Investor Q2 2026 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2026 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .